Publications MD MSc S. Schokker
- Position
- PhD Candidate
- Main activities
- Research
- Specialisation
- Medical Oncology: translational research in esophagogastric carcinoma
- Focus of research
Translational research in esophagogastric carcinoma
I coordinate 5 clinical trials wherein I also perform translational research
ACTION: a phase Ib study on the addition of Nab-Paclitaxel to capecitabine and oxaliplatin in the first line treatment of metastatic esophagogastric carcinoma
PERFECT: PDL-1 targetin in resectable esophageal cancer: a phase II feasibility study of Atezolizumab and chemoradiation
REPEAT: Regorafenib in combination with paclitaxel in advanced esophagogastric carcinoma, a phase 1b study
SOX: feasibility study of adjuvant treatment with S-1 and oxaliplatin in patients with resectable esophageal cancer
TRAP: feasibility study of chemoradiation, Trastuzumab and Pertuzumab in resectable HER2+ esophageal carcinoma
Amsterdam UMC Research Institutes
AMC departments
All publications
2020
- Strijker Marin, Soer Eline C., de Pastena Matteo, Creemers Aafke, Balduzzi Alberto, Beagan Jamie J., Busch Olivier R., van Delden Otto M., Halfwerk Hans, van Hooft Jeanin E., van Lienden Krijn P., Marchegiani Giovanni, Meijer Sybren L., van Noesel Carel J., Reinten Roy J., Roos Eva, Schokker Sandor, Verheij Joanne, van de Vijver Marc J., Waasdorp Cynthia, Wilmink Johanna W., Ylstra Bauke, Besselink Marc G., Bijlsma Maarten F., Dijk Frederike, van Laarhoven Hanneke W. Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal adenocarcinoma International journal of cancer. Journal international du cancer 2020;146 (5):1445-1456 [PubMed]
- Schokker Sandor, Fusetti Fabrizia, Bonardi Francesco, Molenaar Remco J., Mathôt Ron A. A., van Laarhoven Hanneke W. M. Development and validation of an LC-MS/MS method for simultaneous quantification of co-administered trastuzumab and pertuzumab mAbs 2020;12 (1) [PubMed]
- Stroes Charlotte I., Schokker Sandor, Creemers Aafke, Molenaar Remco J., Hulshof Maarten C. C. M., van der Woude Stephanie O., Bennink Roel J., Mathôt Ron A. A., Krishnadath Kausilia K., Punt Cornelis J. A., Verhoeven Rob H. A., van Oijen Martijn G. H., Creemers Geert-Jan, Nieuwenhuijzen Grard A. P., van der Sangen Maurice J. C., Beerepoot Laurens V., Heisterkamp Joos, Los Maartje, Slingerland Marije, Cats Annemieke, Hospers Geke A. P., Bijlsma Maarten F., van Berge Henegouwen Mark I., Meijer Sybren L., van Laarhoven Hanneke W. M. Phase II Feasibility and Biomarker Study of Neoadjuvant Trastuzumab and Pertuzumab With Chemoradiotherapy for Resectable Human Epidermal Growth Factor Receptor 2-Positive Esophageal Adenocarcinoma: TRAP Study Journal of clinical oncology 2020;38 (5):462-471 [PubMed]
- van Kleef Jessy Joy, ter Veer Emil, van den Boorn H. ctor G., Schokker Sandor, Ngai Lok Lam, Prins Mariska J., Mohammad Nadia Haj, van de Poll-Franse Lonneke V., Zwinderman Aeilko H., van Oijen Martijn G. H., Sprangers Mirjam A. G., van Laarhoven Hanneke W. M. Quality of Life During Palliative Systemic Therapy for Esophagogastric Cancer: Systematic Review and Meta-Analysis: systematic review and meta-analysis Journal of the National Cancer Institute 2020;112 (1):12-29 [PubMed]
2019
- Schokker Sandor, van der Woude Stephanie O., van Kleef Jessy Joy, van Zoen Daan J., van Oijen Martijn G. H., Mearadji Banafsche, Beenen Ludo F. M., Stroes Charlotte I., Waasdorp Cynthia, Jibodh R. Aarti, Creemers Aafke, Meijer Sybren L., Hooijer Gerrit K. J., Punt Cornelis J. A., Bijlsma Maarten F., van Laarhoven Hanneke W. M. Phase I Dose escalation study with expansion cohort of the addition of nab-paclitaxel to capecitabine and oxaliplatin (CapOx) as first-line treatment of metastatic esophagogastric adenocarcinoma (ACTION study) Cancers 2019;11 (6) [PubMed]
2018
- ter Veer Emil, van Kleef Jessy Joy, Schokker Sandor, van der Woude Stephanie O., Laarman Marety, Haj Mohammad Nadia, Sprangers Mirjam A. G., van Oijen Martijn G. H., van Laarhoven Hanneke W. M. Prognostic and predictive factors for overall survival in metastatic oesophagogastric cancer: A systematic review and meta-analysis European journal of cancer (Oxford, England 2018;103:214-226 [PubMed]
2014
- Zijlstra Willemijn M. H., Douwes Johannes M., Rosenzweig Erika B., Schokker Sandor, Krishnan Usha, Roofthooft Marcus T. R., Miller-Reed Kathleen, Hillege Hans L., Ivy D. Dunbar, Berger Rolf M. F. Survival differences in pediatric pulmonary arterial hypertension: clues to a better understanding of outcome and optimal treatment strategies Journal of the American College of Cardiology 2014;63 (20):2159-2169 [PubMed]